Joint Use of a Chitosan/PLGA Scaffold and MSCs to Bridge an Extra Large Gap in Dog Sciatic Nerve

被引:62
作者
Xue, Chengbin [2 ]
Hu, Nan
Gu, Yun
Yang, Yumin
Liu, Yan
Liu, Jie
Ding, Fei
Gu, Xiaosong [1 ,2 ]
机构
[1] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, JS, Peoples R China
[2] Nanjing Univ, Nanjing, Jiangsu, Peoples R China
关键词
nerve grafts; peripheral nerve regeneration; chitosan; poly(lactic-co-glycolic acid); bone marrow mesenchymal stem cells; dog sciatic nerve; MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; PERIPHERAL-NERVE; SCHWANN-CELLS; REGENERATION; REPAIR; TRANSPLANTATION; CULTURES; GRAFTS; STRATEGIES;
D O I
10.1177/1545968311420444
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background. Tissue-engineered nerve grafts (TENGs) constitute a promising alternative to nerve autografts that are recognized as the gold standard for surgical repair of peripheral nerve gaps. Objective. To investigate the feasibility of using TENGs for bridging extra large peripheral nerve gaps in large animals. Methods. TENGs were constructed by incorporating autologous bone marrow mesenchymal stem cells (MSCs) into a neural scaffold that consisted of a chitosan conduit inserted with poly(lactic-co-glycolic acid) (PLGA) fibers. A 60-mm-long sciatic nerve gap in dogs was bridged by TENGs, chitosan/PLGA scaffolds, or nerve autografts. At 12 months postsurgery, behavioral analysis, electrophysiology, retrograde fluorogold tracing, and histological examination were performed. Results. The outcomes of TENGs were similar to those of autografts and better than those of scaffolds alone. Conclusion. Introduction of autologous MSCs to a chitosan/PLGA scaffold improved the repair and rehabilitation of a large gap after peripheral nerve injury in dogs. Autologous MSCs may be a source of support cells for neural tissue engineering.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 40 条
[1]
Human mesenchymal stem cells: from basic biology to clinical applications [J].
Abdallah, B. M. ;
Kassem, M. .
GENE THERAPY, 2008, 15 (02) :109-116
[2]
REGENERATION IN THE ADULT MAMMALIAN CNS - GUIDED BY DEVELOPMENT [J].
AUBERT, I ;
RIDET, JL ;
GAGE, FH .
CURRENT OPINION IN NEUROBIOLOGY, 1995, 5 (05) :625-635
[3]
Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium [J].
Bartunek, Jozef ;
Croissant, Jeffrey D. ;
Wijns, William ;
Gofflot, Stephanie ;
de Lavareille, Aurore ;
Vanderheyden, Marc ;
Kaluzhny, Yulia ;
Mazouz, Naima ;
Willemsen, Philippe ;
Penicka, Martin ;
Mathieu, Myrielle ;
Homsy, Christian ;
De Bruyne, Bernard ;
McEntee, Kathleen ;
Lee, Ike W. ;
Heyndrickx, Guy R. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (02) :H1095-H1104
[4]
Bone marrow stromal stem cells: Nature, biology, and potential applications [J].
Bianco, P ;
Riminucci, M ;
Gronthos, S ;
Robey, PG .
STEM CELLS, 2001, 19 (03) :180-192
[5]
Schwann cell-enriched cultures from adult human peripheral nerve:: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C) [J].
Calderón-Martínez, D ;
Garavito, Z ;
Spinel, C ;
Hurtado, H .
JOURNAL OF NEUROSCIENCE METHODS, 2002, 114 (01) :1-8
[6]
Collagen-GAG substrate enhances the quality of nerve regeneration through collagen tubes up to level of autograft [J].
Chamberlain, LJ ;
Yannas, IV ;
Hsu, HP ;
Strichartz, G ;
Spector, M .
EXPERIMENTAL NEUROLOGY, 1998, 154 (02) :315-329
[7]
Study of in vivo differentiation of rat bone marrow stromal cells into Schwann cell-like cells [J].
Chen, X ;
Wang, XD ;
Chen, G ;
Lin, WW ;
Yao, J ;
Gu, XS .
MICROSURGERY, 2006, 26 (02) :111-115
[8]
Peripheral nerve regeneration by bone marrow stromal cells [J].
Cuevas, P ;
Carceller, F ;
Dujovny, M ;
Garcia-Gómez, I ;
Cuevas, B ;
González-Corrochano, R ;
Diaz-González, D ;
Reimers, D .
NEUROLOGICAL RESEARCH, 2002, 24 (07) :634-638
[9]
DERYUGINA EI, 1993, CRIT REV IMMUNOL, V13, P115
[10]
Treatment of neurodegenerative diseases using adult bone marrow stromal cell-derived neurons [J].
Dezawa, M ;
Hoshino, M ;
Ide, C .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) :427-435